Dow Jones U.S. Pharmaceuticals Index Fund (IHE) Inception date: 5/1/2006
Holdings Detail as of 11/6/2009 (Holdings subject to change)
| Stock | 99.74% |
| Cash | 0.11% |
| Other* | 0.14% |
*May include dividends booked but not yet received.
Identifiers/Cusips are only available to users who are signed in. Please sign in now.
| Symbol | Name |
% Net Assets |
Market Value ($) |
Identifier* | Market | Sector |
Exchange Rate |
|---|---|---|---|---|---|---|---|
| MRK | MERCK&CO. INC. | 9.70 | $13,195,202 | -- | XNYS | Pharmaceuticals | 1.00 |
| PFE | PFIZER INC | 9.54 | $12,982,100 | -- | XNYS | Pharmaceuticals | 1.00 |
| JNJ | JOHNSON&JOHNSON | 8.71 | $11,853,714 | -- | XNYS | Pharmaceuticals | 1.00 |
| ABT | ABBOTT LABORATORIES | 7.42 | $10,093,593 | -- | XNYS | Pharmaceuticals | 1.00 |
| BMY | BRISTOL-MYERS SQUIBB CO | 5.83 | $7,927,238 | -- | XNYS | Pharmaceuticals | 1.00 |
| LLY | ELI LILLY&CO | 5.46 | $7,422,261 | -- | XNYS | Pharmaceuticals | 1.00 |
| AGN | ALLERGAN INC | 4.54 | $6,176,753 | -- | XNYS | Pharmaceuticals | 1.00 |
| HSP | HOSPIRA INC | 3.71 | $5,047,188 | -- | XNYS | Pharmaceuticals | 1.00 |
| FRX | FOREST LABORATORIES INC | 3.48 | $4,728,371 | -- | XNYS | Pharmaceuticals | 1.00 |
| MYL | MYLAN INC | 3.29 | $4,480,566 | -- | XNGS | Pharmaceuticals | 1.00 |
| PRGO | PERRIGO CO | 3.05 | $4,154,451 | -- | XNGS | Pharmaceuticals | 1.00 |
| CEPH | CEPHALON INC | 2.83 | $3,844,344 | -- | XNGS | Pharmaceuticals | 1.00 |
| WPI | WATSON PHARMACEUTICALS INC | 2.66 | $3,613,647 | -- | XNYS | Pharmaceuticals | 1.00 |
| VRX | VALEANT PHARMACEUTICALS INTE | 2.61 | $3,556,917 | -- | XNYS | Pharmaceuticals | 1.00 |
| KG | KING PHARMACEUTICALS INC | 2.54 | $3,451,178 | -- | XNYS | Pharmaceuticals | 1.00 |
| ENDP | ENDO PHARMACEUT HLDGS INC | 2.35 | $3,191,595 | -- | XNGS | Pharmaceuticals | 1.00 |
| SLXP | SALIX PHARMACEUTICALS LTD | 2.31 | $3,149,125 | -- | XNMS | Pharmaceuticals | 1.00 |
| MRX | MEDICIS PHARMACEUTICAL-CL A | 2.14 | $2,907,325 | -- | XNYS | Pharmaceuticals | 1.00 |
| AUXL | AUXILIUM PHARMACEUTICALS INC | 2.10 | $2,855,511 | -- | XNGS | Pharmaceuticals | 1.00 |
| MDVN | MEDIVATION INC | 1.84 | $2,501,126 | -- | XNMS | Pharmaceuticals | 1.00 |
| AMAG | AMAG PHARMACEUTICALS INC | 1.71 | $2,323,334 | -- | XNMS | Pharmaceuticals | 1.00 |
| PRX | PAR PHARMACEUTICAL COS INC | 1.62 | $2,209,218 | -- | XNYS | Pharmaceuticals | 1.00 |
| RIGL | RIGEL PHARMACEUTICALS INC | 1.54 | $2,098,403 | -- | XNMS | Pharmaceuticals | 1.00 |
| VPHM | VIROPHARMA INC | 1.41 | $1,923,189 | -- | XNGS | Pharmaceuticals | 1.00 |
| THRX | THERAVANCE INC | 1.40 | $1,910,297 | -- | XNMS | Pharmaceuticals | 1.00 |
| ALKS | ALKERMES INC | 1.38 | $1,883,928 | -- | XNGS | Pharmaceuticals | 1.00 |
| XNPT | XENOPORT INC | 1.34 | $1,825,029 | -- | XNGS | Pharmaceuticals | 1.00 |
| VVUS | VIVUS INC | 1.15 | $1,567,729 | -- | XNMS | Pharmaceuticals | 1.00 |
| PBH | PRESTIGE BRANDS HOLDINGS INC | 1.12 | $1,517,842 | -- | XNYS | Pharmaceuticals | 1.00 |
| MDCO | MEDICINES COMPANY | 0.97 | $1,323,021 | -- | XNGS | Pharmaceuticals | 1.00 |
| -- | BGIF TREASURY MONEY MARKET SL AGENCY SHARES | 0.11 | $153,199 | -- | -- | S-T Securities | 1.00 |
*Securities primarily traded in the U.S. market use CUSIP identifiers. Securities primarily traded abroad use a 6-digit SEDOL™ with a trailing check digit and a "99" at the beginning for internal coding purposes. If a SEDOL™ is unavailable, the first seven digits of the ISIN are used.
Please note: Total allocation percentages may not equal 100% due to rounding or omission of holdings of less than 1%. Information on certain fund holdings of less than 1% may not be widely available and may not be included in this list.
SEDOL™ is a trademark of the London Stock Exchange plc and used under license.
Please note: Total allocation percentages may not equal 100% due to rounding or omission of holdings of less than 1%. Information on certain fund holdings of less than 1% may not be widely available and may not be included in this list.
SEDOL™ is a trademark of the London Stock Exchange plc and used under license.
© Copyright 2009